Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
79.49
+4.39 (5.85%)
At close: Jan 22, 2026, 4:00 PM EST
78.61
-0.88 (-1.11%)
After-hours: Jan 22, 2026, 4:54 PM EST
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.16 billion as of January 22, 2026. Its market cap has increased by 394.50% in one year.
Market Cap
1.16B
Enterprise Value
1.11B
1-Year Change
394.50%
Ranking
Category
Stock Price
$79.49
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.16B, an increase of 483.18%. That is a compound annual growth rate of 191.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.09B | -4.94% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.15B |
| ORIC Pharmaceuticals | 1.13B |
| Zenas BioPharma | 1.12B |
| Phathom Pharmaceuticals | 1.11B |
| Theravance Biopharma | 1.03B |
| ARS Pharmaceuticals | 1.03B |
| Compass Therapeutics | 1.02B |
| Nanobiotix | 1.01B |